NLRP3 and atherosclerosis: The study of bone marrow-derived mesenchymal stem cells microvesicles (BMSCs-MVs) on the treatment of atherosclerosis in mice showed that miR-223 inhibited macrophages pyroptosis by reducing the expression of NLRP3 (Lin et al., 2020).